About Us
QuantHealth is a pioneering AI-driven healthcare company transforming drug development through its advanced clinical trial simulations
Quant What?
Founded in 2020, QuantHealth has successfully simulated over 120 clinical trials with an impressive 85% accuracy.
Its cutting-edge in-silico platform enables pharmaceutical and biotechnology companies to accelerate and de-risk their development processes.
Redefining Clinical Development
Trusted by many of the world’s top 50 pharmaceutical companies, QuantHealth's technology predicts how any patient will respond to any treatment, supporting smarter trial planning, indication selection, drug in-licensing, and portfolio optimization.
By generating synthetic evidence across all clinical phases, QuantHealth is shaping the future of healthcare.
Our Vision
At QuantHealth, our vision is to transform the future of healthcare by accelerating the development of groundbreaking therapies. We are committed to bringing more and better treatments to patients worldwide, faster and more affordably than ever before. Paving the way for a healthier, more hopeful future.
By the Numbers
>10K
Data points per patient
Over
120
Trials simulated
Over
45
Diseases
85%
Endpoint prediction accuracy
>100K
Drug & mechanism data points
350M
Lives
Our Award-Winning Platform
Proud to Partner with
Proudly Supported by
Leadership
At QuantHealth, our team embodies a remarkable fusion of talent, expertise, and dedication. Comprising a large and diverse group of professionals, we bring together specialists from a wide array of disciplines, including data science, biology, medicine, bioinformatics, mathematics, software engineering, product management, immunology, pharmacology, and epidemiology.
Our team members boast backgrounds from leading academic institutions and top-tier industry roles, ensuring that we operate at the forefront of innovation and excellence. With 36% of our team holding PhDs or MDs and 75% possessing advanced degrees, we are not just highly qualified—we are passionate about what we do. Known for being exceptionally nice, incredibly dedicated, and unfailingly professional, our team is united by a common goal: to revolutionize healthcare and make a profound impact on the future of medicine.
QuantHealth in the Press
20 Pharmaceutical Companies in Israel to Know
December 23, 2024
Israeli pharmaceutical companies are leveraging biotech and synthetics to craft modern drugs and therapies for numerous health conditions
Read more
Why Breaking Into Healthcare Is So Hard—How To Overcome The Barrier
December 09, 2024
The healthcare industry is like a fortress in more ways than one. Being the first and last line of defense when it comes to our wellbeing places a unique pressure on the industry to stick with what works, which is why breakthroughs, such as new drugs, can take decades to get from the lab to end users. It’s an industry where mistakes can cost lives, and failing fast, or failing at all for that matter, isn’t an option.
Read more
AI Simulations Help Drug Trials
October 10, 2024
Artificial intelligence (AI) has been revolutionizing much of early drug discovery, yet human clinical trials remain a bottleneck. Now some applications of the new technologies are bringing efficiencies to clinical research.
Read more
OMNY Health takes first steps into AI partnerships with Aris Global and Quant Health
July 02, 2024
Healthcare data company OMNY Health announced partnerships with two healthcare artificial intelligence companies, Aris Global and Quant Health on Tuesday.
Read more
This startup uses AI to simulate clinical trials and speed new drugs to market
March 19, 2024
Tel Aviv-based QuantHealth is one of Fast Company’s Most Innovative Companies in Europe, the Middle East, and Africa for 2024.
Read more
AI-powered trial designer QuantHealth gets ‘strategic investment’ boost from Accenture
January 18, 2024
QuantHealth, which uses AI to develop clinical trials, received a strategic investment from Accenture as part of the professional services giant’s Project Spotlight program.
Read more
QuantHealth brings its AI-informed clinical drug trials to the US with $15M round
August 30, 2023
Biotech, pharmaceutical and life sciences companies all hope AI will streamline drug development and make it more efficient, and 38% have already adopted the technology, according to Deloitte. QuantHealth aims to take part with a model that predicts risks and outcomes for clinical trials.
Read more
QuantHealth taking a data-driven predictive approach to simulate clinical trials
July 20, 2023
In drug discovery, the process of shooting for regulatory approval can feel less like a sprint and more like a marathon, but with no guarantee of crossing the finish line.
Read more
Six Israeli startups selected to participate in BeyondBio SCALE program
December 18, 2022
Improving cancer treatment, enabling efficient ways for sharing of data for advanced research, and AI for predicting drug safety, are all among the innovative solutions developed by the six startups selected for BeyondBio SCALE - a joint innovation program of AstraZeneca, Accenture, Clalit and AWS
Read more
4P-Pharma and QuantHealth join forces to conduct AI-based in-Silico clinical trial simulations
March 03, 2022
4P-Pharma signs a partnership with QuantHealth, a data science start-up taking a unique in-silico approach to clinical trial simulations based on broad real-world data (RWD) and deep molecular drug data. Together, we will conduct in silico clinical trials of our lead drug candidates.
Read more